PA
MYGN icon

Parallel Advisors’s Myriad Genetics MYGN Stock Holding History

Parallel Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92K Sell
687
-669
-49% -$3.04K ﹤0.01% 3312
2026
Q1 		$6.1K Buy
1,356
+614
+83% +$3.2K ﹤0.01% 2963
2025
Q4 		$4.56K Hold
742
– – ﹤0.01% 2878
2025
Q3 		$5.37K Sell
742
-216
-23% -$1.28K ﹤0.01% 2751
2025
Q2 		$5.09K Buy
958
+812
+556% +$4.8K ﹤0.01% 2741
2025
Q1 		$1.29K Buy
146
+24
+20% +$288 ﹤0.01% 3068
2024
Q4 		$1.67K Sell
122
-651
-84% -$12K ﹤0.01% 3014
2024
Q3 		$21.2K Hold
773
– – ﹤0.01% 2069
2024
Q2 		$18.9K Sell
773
-3
-0.4% -$66 ﹤0.01% 2028
2024
Q1 		$16.5K Sell
776
-33
-4% -$709 ﹤0.01% 2079
2023
Q4 		$15.5K Buy
809
+708
+701% +$12.2K ﹤0.01% 2096
2023
Q3 		$1.62K Hold
101
– – ﹤0.01% 2877
2023
Q2 		$2.34K Sell
101
-10
-9% -$218 ﹤0.01% 2707
2023
Q1 		$2.58K Sell
111
-12
-10% -$244 ﹤0.01% 2668
2022
Q4 		$1.78K Buy
123
+3
+3% +$56 ﹤0.01% 2725
2022
Q3 		$2K Buy
120
+19
+19% +$436 ﹤0.01% 2700
2022
Q2 		$2K Buy
101
+10
+11% +$208 ﹤0.01% 2602
2022
Q1 		$2K Hold
91
– – ﹤0.01% 2598
2021
Q4 		$3K Hold
91
– – ﹤0.01% 2594
2021
Q3 		$3K Buy
91
+19
+26% +$631 ﹤0.01% 2576
2021
Q2 		$2K Hold
72
– – ﹤0.01% 2585
2021
Q1 		$2K Buy
+72
New +$2.04K ﹤0.01% 2491
2018
Q4 		– Sell
-14
Closed -$1K – 2218
2018
Q3 		$1K Buy
+14
New +$623 ﹤0.01% 2147

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Parallel Advisors's MYGN Position: Q2 2026 in Review

Parallel Advisors reduced its Myriad Genetics (MYGN) stake by 49% in Q2 2026, selling an estimated $3.04K and leaving 687 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #3312.

Parallel Advisors first reported a position in MYGN in Q3 2018 and has held it in 23 quarters since. The position peaked at $21.2K in Q3 2024. 59 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Parallel Advisors held 687 shares of Myriad Genetics worth $3.92K as of Q2 2026.
  • Parallel Advisors sold 669 Myriad Genetics shares in Q2 2026, an estimated $3.04K.
  • Myriad Genetics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3312 holding.
  • Parallel Advisors first reported a position in Myriad Genetics in Q3 2018 and has held it in 23 quarters since.
  • Parallel Advisors's Myriad Genetics position peaked at $21.2K in Q3 2024.
  • 59 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.